Home
About
Overview
Sharing Data
ORCID
Help
History (30)
Pripstein, Jeremy
Treatment rationale and study design for the pointbreak study: a randomized, open-label phase III study of pemetrexed/carboplatin/bevacizumab followed by maintenance pemetrexed/bevacizumab versus paclitaxel/carboplatin/bevacizumab followed by maintenance bevacizumab in patients with stage IIIB or IV nonsquamous non-small-cell lung cancer.
Anorectal Malformations
Enzymatic disease of the podocyte.
Understanding the molecular manipulation of DCAF1 by the lentiviral accessory proteins Vpr and Vpx.
See All 30 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Understanding the molecular manipulation of DCAF1 by the lentiviral accessory proteins Vpr and Vpx.
Understanding the molecular manipulation of DCAF1 by the lentiviral accessory proteins Vpr and Vpx. Virology. 2015 Feb; 476:19-25.
View in:
PubMed
subject areas
Amino Acid Motifs
Amino Acid Sequence
Carrier Proteins
HIV-1
Humans
Molecular Sequence Data
Protein Binding
Protein Structure, Tertiary
Sequence Alignment
Simian Immunodeficiency Virus
Ubiquitin-Protein Ligases
Viral Regulatory and Accessory Proteins
vpr Gene Products, Human Immunodeficiency Virus
authors with profiles
Edward Barker